These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 27262568)

  • 1. Persisters-as elusive as ever.
    Kaldalu N; Hauryliuk V; Tenson T
    Appl Microbiol Biotechnol; 2016 Aug; 100(15):6545-6553. PubMed ID: 27262568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidrug tolerance of biofilms and persister cells.
    Lewis K
    Curr Top Microbiol Immunol; 2008; 322():107-31. PubMed ID: 18453274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formation, physiology, ecology, evolution and clinical importance of bacterial persisters.
    Van den Bergh B; Fauvart M; Michiels J
    FEMS Microbiol Rev; 2017 May; 41(3):219-251. PubMed ID: 28333307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persisters and beyond: mechanisms of phenotypic drug resistance and drug tolerance in bacteria.
    Kester JC; Fortune SM
    Crit Rev Biochem Mol Biol; 2014; 49(2):91-101. PubMed ID: 24328927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneous bacterial persisters and engineering approaches to eliminate them.
    Allison KR; Brynildsen MP; Collins JJ
    Curr Opin Microbiol; 2011 Oct; 14(5):593-8. PubMed ID: 21937262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The drug tolerant persisters of Riemerella anatipestifer can be eradicated by a combination of two or three antibiotics.
    Tang T; Wu Y; Lin H; Li Y; Zuo H; Gao Q; Wang C; Pei X
    BMC Microbiol; 2018 Oct; 18(1):137. PubMed ID: 30340538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms and clinical implications of bacterial persistence.
    Michiels JE; Van den Bergh B; Verstraeten N; Michiels J
    Drug Resist Updat; 2016 Nov; 29():76-89. PubMed ID: 27912845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metamorphoses of Lyme disease spirochetes: phenomenon of Borrelia persisters.
    Rudenko N; Golovchenko M; Kybicova K; Vancova M
    Parasit Vectors; 2019 May; 12(1):237. PubMed ID: 31097026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innate and induced resistance mechanisms of bacterial biofilms.
    Anderson GG; O'Toole GA
    Curr Top Microbiol Immunol; 2008; 322():85-105. PubMed ID: 18453273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should we develop screens for multi-drug antibiotic tolerance?
    Van den Bergh B; Michiels JE; Fauvart M; Michiels J
    Expert Rev Anti Infect Ther; 2016 Jul; 14(7):613-6. PubMed ID: 27227426
    [No Abstract]   [Full Text] [Related]  

  • 11. Phenotypic and genetic heterogeneity within biofilms with particular emphasis on persistence and antimicrobial tolerance.
    Sadiq FA; Flint S; Li Y; Ou K; Yuan L; He GQ
    Future Microbiol; 2017 Sep; 12():1087-1107. PubMed ID: 28783379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic treatment of biofilm infections.
    Ciofu O; Rojo-Molinero E; Macià MD; Oliver A
    APMIS; 2017 Apr; 125(4):304-319. PubMed ID: 28407419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent bacterial infections and persister cells.
    Fisher RA; Gollan B; Helaine S
    Nat Rev Microbiol; 2017 Aug; 15(8):453-464. PubMed ID: 28529326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial Persisters and Infection: Past, Present, and Progressing.
    Gollan B; Grabe G; Michaux C; Helaine S
    Annu Rev Microbiol; 2019 Sep; 73():359-385. PubMed ID: 31500532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Antibiotic Tolerance, Pathogen by Pathogen.
    Meylan S; Andrews IW; Collins JJ
    Cell; 2018 Mar; 172(6):1228-1238. PubMed ID: 29522744
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Kaldalu N; Hauryliuk V; Turnbull KJ; La Mensa A; Putrinš M; Tenson T
    Microbiol Mol Biol Rev; 2020 Nov; 84(4):. PubMed ID: 33177189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial persisters: formation, eradication, and experimental systems.
    Helaine S; Kugelberg E
    Trends Microbiol; 2014 Jul; 22(7):417-24. PubMed ID: 24768561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment strategies targeting persister cell formation in bacterial pathogens.
    Khan F; Pham DTN; Tabassum N; Oloketuyi SF; Kim YM
    Crit Rev Microbiol; 2020 Nov; 46(6):665-688. PubMed ID: 33022189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repurposing of Anticancer Drugs for the Treatment of Bacterial Infections.
    Soo VW; Kwan BW; Quezada H; Castillo-Juárez I; Pérez-Eretza B; García-Contreras SJ; Martínez-Vázquez M; Wood TK; García-Contreras R
    Curr Top Med Chem; 2017; 17(10):1157-1176. PubMed ID: 27697046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic persistence and tolerance: not just one and the same.
    Ronneau S; Hill PW; Helaine S
    Curr Opin Microbiol; 2021 Dec; 64():76-81. PubMed ID: 34634678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.